Multifaceted Fanconi Anemia Signaling

Overview

Journal Trends Genet

Specialty Genetics

Date 2017 Dec 20

PMID 29254745

Citations 51

Authors

Raymond Che

Jun Zhang

Manoj Nepal

Bing Han

Peiwen Fei

Affiliations

Soon will be listed here.

Abstract

In 1927 Guido Fanconi described a hereditary condition presenting panmyelopathy accompanied by short stature and hyperpigmentation, now better known as Fanconi anemia (FA). With this discovery the genetic and molecular basis underlying FA has emerged as a field of great interest. FA signaling is crucial in the DNA damage response (DDR) to mediate the repair of damaged DNA. This has attracted a diverse range of investigators, especially those interested in aging and cancer. However, recent evidence suggests FA signaling also regulates functions outside the DDR, with implications for many other frontiers of research. We discuss here the characteristics of FA functions and expand upon current perspectives regarding the genetics of FA, indicating that FA plays a role in a myriad of molecular and cellular processes.

Citing Articles

Transcription-coupled repair - mechanisms of action, regulation, and associated human disorders.

Nakazawa Y, Oka Y, Matsunaga T, Ogi T FEBS Lett. 2024; 599(2):166-167.

PMID: 39704188 PMC: 11771657. DOI: 10.1002/1873-3468.15073.

Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition).

Zhao B, Zhou X, Zheng P, Zhang B, Feng X, Chen J Front Pharmacol. 2024; 15:1477550.

PMID: 39650164 PMC: 11621627. DOI: 10.3389/fphar.2024.1477550.

Fanconi Anemia: Challenges in Diagnosis and Management-A Case Series Report.

Eghbali A, Safdari S, Yousefi Roozbahani M, Tavajohi K, Hosseini S Clin Case Rep. 2024; 12(11):e9583.

PMID: 39559288 PMC: 11570422. DOI: 10.1002/ccr3.9583.

New Insights into the Fanconi Anemia Pathogenesis: A Crosstalk Between Inflammation and Oxidative Stress.

Repczynska A, Ciastek B, Haus O Int J Mol Sci. 2024; 25(21).

PMID: 39519169 PMC: 11547024. DOI: 10.3390/ijms252111619.

Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors.

Rai S, Du W, Zhang J, Yu H, Deng Y, Fei P Front Med (Lausanne). 2024; 11:1462810.

PMID: 39421870 PMC: 11483370. DOI: 10.3389/fmed.2024.1462810.

References

Inano S, Sato K, Katsuki Y, Kobayashi W, Tanaka H, Nakajima K . RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination. Mol Cell. 2017; 66(5):622-634.e8. DOI: 10.1016/j.molcel.2017.04.022. View

Svendsen J, Smogorzewska A, Sowa M, OConnell B, Gygi S, Elledge S . Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell. 2009; 138(1):63-77. PMC: 2720686. DOI: 10.1016/j.cell.2009.06.030. View

Taniguchi T, DAndrea A . Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006; 107(11):4223-33. DOI: 10.1182/blood-2005-10-4240. View

Meetei A, Levitus M, Xue Y, Medhurst A, Zwaan M, Ling C . X-linked inheritance of Fanconi anemia complementation group B. Nat Genet. 2004; 36(11):1219-24. DOI: 10.1038/ng1458. View

Sawyer S, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J . Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov. 2014; 5(2):135-42. PMC: 4320660. DOI: 10.1158/2159-8290.CD-14-1156. View

Xu S, Li W, Zhu J, Wang R, Li Z, Xu G . Crystal structures of isoorotate decarboxylases reveal a novel catalytic mechanism of 5-carboxyl-uracil decarboxylation and shed light on the search for DNA decarboxylase. Cell Res. 2013; 23(11):1296-309. PMC: 3817540. DOI: 10.1038/cr.2013.107. View

Panneerselvam J, Xie G, Che R, Su M, Zhang J, Jia W . Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway. J Proteome Res. 2016; 15(4):1333-41. PMC: 4874490. DOI: 10.1021/acs.jproteome.6b00076. View

Klein H, Symington L . Breaking up just got easier to do. Cell. 2009; 138(1):20-2. DOI: 10.1016/j.cell.2009.06.039. View

Ceccaldi R, Sarangi P, DAndrea A . The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016; 17(6):337-49. DOI: 10.1038/nrm.2016.48. View

10.

Wang A, Kim T, Wagner J, Conti B, Lach F, Huang A . A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination. Mol Cell. 2015; 59(3):478-90. PMC: 4529964. DOI: 10.1016/j.molcel.2015.07.009. View

11.

Moldovan G, DAndrea A . How the fanconi anemia pathway guards the genome. Annu Rev Genet. 2009; 43:223-49. PMC: 2830711. DOI: 10.1146/annurev-genet-102108-134222. View

12.

Panneerselvam J, Pickering A, Zhang J, Wang H, Tian H, Zheng J . A hidden role of the inactivated FANCD2: upregulating ΔNp63. Oncotarget. 2013; 4(9):1416-26. PMC: 3824532. DOI: 10.18632/oncotarget.1217. View

13.

Shen Y, Zhang J, Yu H, Fei P . Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer. Cancer Cell Microenviron. 2015; 2(4). PMC: 4667986. DOI: 10.14800/ccm.986. View

14.

Osorio A, Bogliolo M, Fernandez V, Barroso A, de la Hoya M, Caldes T . Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Hum Mutat. 2013; 34(12):1615-8. DOI: 10.1002/humu.22438. View

15.

Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A . Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet. 2013; 92(5):800-6. PMC: 3644630. DOI: 10.1016/j.ajhg.2013.04.002. View

16.

Rajendra E, Oestergaard V, Langevin F, Wang M, Dornan G, Patel K . The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell. 2014; 54(5):858-69. PMC: 4051986. DOI: 10.1016/j.molcel.2014.05.001. View

17.

Rickman K, Lach F, Abhyankar A, Donovan F, Sanborn E, Kennedy J . Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia. Cell Rep. 2015; 12(1):35-41. PMC: 4497947. DOI: 10.1016/j.celrep.2015.06.014. View

18.

Meetei A, Medhurst A, Ling C, Xue Y, Singh T, Bier P . A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005; 37(9):958-63. PMC: 2704909. DOI: 10.1038/ng1626. View

19.

Dicks E, Song H, Ramus S, Van Oudenhove E, Tyrer J, Intermaggio M . Germline whole exome sequencing and large-scale replication identifies as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget. 2017; 8(31):50930-50940. PMC: 5584218. DOI: 10.18632/oncotarget.15871. View

20.

Zhang X, Lu X, Akhter S, Georgescu M, Legerski R . FANCI is a negative regulator of Akt activation. Cell Cycle. 2016; 15(8):1134-43. PMC: 4889286. DOI: 10.1080/15384101.2016.1158375. View